BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11301402)

  • 1. Systematic review of the diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography in melanoma patients.
    Mijnhout GS; Hoekstra OS; van Tulder MW; Teule GJ; Devillé WL
    Cancer; 2001 Apr; 91(8):1530-42. PubMed ID: 11301402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma.
    Jiménez-Requena F; Delgado-Bolton RC; Fernández-Pérez C; Gambhir SS; Schwimmer J; Pérez-Vázquez JM; Carreras-Delgado JL
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):284-300. PubMed ID: 19727717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of positron emission tomography scan in stage III cutaneous melanoma: a systematic review and meta-analysis.
    Rodriguez Rivera AM; Alabbas H; Ramjaun A; Meguerditchian AN
    Surg Oncol; 2014 Mar; 23(1):11-6. PubMed ID: 24556310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of PET in the initial staging of cutaneous malignant melanoma: systematic review.
    Krug B; Crott R; Lonneux M; Baurain JF; Pirson AS; Vander Borght T
    Radiology; 2008 Dec; 249(3):836-44. PubMed ID: 19011184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
    Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
    Lin CY; Lin CL; Kao CH
    Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
    Treglia G; Sadeghi R; Annunziata S; Lococo F; Cafarotti S; Bertagna F; Prior JO; Ceriani L; Giovanella L
    Acad Radiol; 2014 Jan; 21(1):11-20. PubMed ID: 24331260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW; Nam SB; Kim SJ
    Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the literature for whole-body FDG PET in the management of patients with melanoma.
    Schwimmer J; Essner R; Patel A; Jahan SA; Shepherd JE; Park K; Phelps ME; Czernin J; Gambhir SS
    Q J Nucl Med; 2000 Jun; 44(2):153-67. PubMed ID: 10967625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with Merkel cell carcinoma: a systematic review and meta-analysis.
    Treglia G; Kakhki VR; Giovanella L; Sadeghi R
    Am J Clin Dermatol; 2013 Dec; 14(6):437-47. PubMed ID: 23959776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT.
    Akcali C; Zincirkeser S; Erbagcý Z; Akcali A; Halac M; Durak G; Sager S; Sahin E
    J Int Med Res; 2007; 35(4):547-53. PubMed ID: 17697533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
    Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J
    Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
    Liu T; Xu JY; Xu W; Bai YR; Yan WL; Yang HL
    Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):350-8. PubMed ID: 21094027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment.
    Zhang S; Han D; Tan X; Feng J; Guo Y; Ding Y
    Int J Clin Pract; 2012 Feb; 66(2):185-98. PubMed ID: 22257044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of FDG-PET versus magnetic resonance imaging for detecting spondylitis: a systematic review and meta-analysis.
    Yin Y; Liu X; Yang X; Guo J; Wang Q; Chen L
    Spine J; 2018 Dec; 18(12):2323-2332. PubMed ID: 30121323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.
    Reinhardt MJ; Joe AY; Jaeger U; Huber A; Matthies A; Bucerius J; Roedel R; Strunk H; Bieber T; Biersack HJ; Tüting T
    J Clin Oncol; 2006 Mar; 24(7):1178-87. PubMed ID: 16505438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies.
    Yu T; Meng N; Chi D; Zhao Y; Wang K; Luo Y
    Cell Biochem Biophys; 2015 Jun; 72(2):443-51. PubMed ID: 25737131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can ¹⁸F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis.
    Chen YM; Pan XF; Tong LJ; Shi YP; Chen T
    Nucl Med Commun; 2011 Nov; 32(11):1005-10. PubMed ID: 21886014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.
    Wagner JD; Schauwecker D; Davidson D; Coleman JJ; Saxman S; Hutchins G; Love C; Hayes JT
    J Clin Oncol; 1999 May; 17(5):1508-15. PubMed ID: 10334538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?
    Wu LM; Xu JR; Gu HY; Hua J; Chen J; Zhang W; Haacke EM; Hu J
    J Surg Res; 2012 Nov; 178(1):304-14. PubMed ID: 22541065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.